PALISADE CAPITAL MANAGEMENT, LP - CONMED CORP ownership

CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 25 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$2,378,685
-39.4%
2,027,000
-19.8%
0.07%
-36.5%
Q2 2023$3,922,409
-3.7%
2,527,000
-22.6%
0.10%
-5.5%
Q1 2023$4,072,166
+8.3%
3,264,0000.0%0.11%
+8.9%
Q4 2022$3,759,802
-2.7%
3,264,000
-8.4%
0.10%
-8.2%
Q3 2022$3,865,000
-10.4%
3,564,0000.0%0.11%
-6.0%
Q2 2022$4,312,000
-29.7%
3,564,0000.0%0.12%
-17.0%
Q1 2022$6,134,000
+2.2%
3,564,000
-1.3%
0.14%
+15.6%
Q4 2021$6,004,000
-22.6%
3,611,000
-27.8%
0.12%
-27.8%
Q3 2021$7,762,000
-7.8%
4,998,000
-4.0%
0.17%
-11.1%
Q2 2021$8,417,000
-14.2%
5,208,000
-17.0%
0.19%
-17.7%
Q1 2021$9,814,000
+32.9%
6,271,000
+19.0%
0.23%
+22.2%
Q4 2020$7,387,000
+25.1%
5,271,0000.0%0.19%
+8.0%
Q3 2020$5,903,000
+39.4%
5,271,000
+31.4%
0.18%
+29.6%
Q2 2020$4,234,000
+24.3%
4,010,000
+9.9%
0.14%
+12.5%
Q1 2020$3,407,0003,650,0000.12%
Other shareholders
CONMED CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Opti Capital Management, LP 50,065,000$86,599,0006.97%
III Capital Management 12,488,000$21,464,0001.87%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,035,000$6,946,0001.55%
SHENKMAN CAPITAL MANAGEMENT INC 6,082,000$10,261,0001.29%
SSI INVESTMENT MANAGEMENT LLC 6,448,000$11,078,0000.60%
MACKAY SHIELDS LLC 38,008,000$65,472,0000.58%
Eisler Capital (UK) Ltd. 9,500,000$16,280,0000.27%
CAPSTONE INVESTMENT ADVISORS, LLC 53,974,000$93,024,0000.26%
OSTERWEIS CAPITAL MANAGEMENT INC 2,607,000$4,493,0000.25%
Polar Asset Management Partners Inc. 10,000,000$17,137,0000.18%
View complete list of CONMED CORP shareholders